On the public citation graph

Appropriate Targets for Antibacterial Drugs

https://doi.org/10.1101/cshperspect.a030239
0 signed · 116 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1007/978-1-4614-1400-1_2openalex-snapshot
Rational Approaches to Antibacterial Discovery: Pre-Genomic Directed and Phenotypic Screening
inferredcites →https://doi.org/10.1007/978-1-4614-1400-1_28openalex-snapshot
Cell-Based Screening in Antibacterial Discovery
inferredcites →https://doi.org/10.1016/j.bcp.2005.11.023openalex-snapshot
Antibacterial drug discovery—Then, now and the genomics future
inferredcites →https://doi.org/10.1016/j.bcp.2005.11.025openalex-snapshot
When will the genomics investment pay off for antibacterial discovery?
inferredcites →https://doi.org/10.1016/j.coph.2008.06.008openalex-snapshot
How many modes of action should an antibiotic have?
inferredcites →https://doi.org/10.1016/s1359-6446(04)03285-4openalex-snapshot
Antibiotics: Where did we go wrong?
inferredcites →https://doi.org/10.1016/s1369-5274(00)00133-8openalex-snapshot
Will genomics revolutionize antimicrobial drug discovery?
inferredcites →https://doi.org/10.1016/s1471-4892(02)00197-2openalex-snapshot
New (and not so new) antibacterial targets – from where and when will the novel drugs come?
inferredcites →https://doi.org/10.1021/jm501552xopenalex-snapshot
Trends and Exceptions of Physical Properties on Antibacterial Activity for Gram-Positive and Gram-Negative Pathogens
inferredcites →https://doi.org/10.1038/ismej.2011.122openalex-snapshot
Quorum quenching quandary: resistance to antivirulence compounds
inferredcites →https://doi.org/10.1038/ismej.2015.84openalex-snapshot
Can resistance against quorum-sensing interference be selected?
inferredcites →https://doi.org/10.1038/nrd2201openalex-snapshot
Drugs for bad bugs: confronting the challenges of antibacterial discovery
inferredcites →https://doi.org/10.1038/nrd2202openalex-snapshot
Multi-targeting by monotherapeutic antibacterials
inferredcites →https://doi.org/10.1038/nrd4572openalex-snapshot
ESKAPEing the labyrinth of antibacterial discovery
inferredcites →https://doi.org/10.1046/j.1365-2672.92.5s1.16.xopenalex-snapshot
Novel targets for the future development of antibacterial agents
inferredcites →https://doi.org/10.1046/j.1365-2958.2002.02832.xopenalex-snapshot
A genome‐wide strategy for the identification of essential genes in Staphylococcus aureus
inferredcites →https://doi.org/10.1093/genetics/123.4.625openalex-snapshot
Genetic analysis of temperature-sensitive lethal mutants of Salmonella typhimurium.
inferredcites →https://doi.org/10.1093/jac/dkr262openalex-snapshot
Discovery research: the scientific challenge of finding new antibiotics
inferredcites →https://doi.org/10.1093/jac/dkr466openalex-snapshot
Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens
inferredcites →https://doi.org/10.1093/jac/dks436openalex-snapshot
The 2012 Garrod Lecture: Discovery of antibacterial drugs in the 21st century
inferredcites →https://doi.org/10.1101/cshperspect.a025304openalex-snapshot
Antibacterial Drug Discovery Targeting the Lipopolysaccharide Biosynthetic Enzyme LpxC
inferredcites →https://doi.org/10.1101/cshperspect.a025437openalex-snapshot
Fusidic Acid: A Bacterial Elongation Factor Inhibitor for the Oral Treatment of Acute and Chronic Staphylococcal Infections
inferredcites →https://doi.org/10.1101/cshperspect.a027045openalex-snapshot
Resistance Mechanisms and the Future of Bacterial Enoyl-Acyl Carrier Protein Reductase (FabI) Antibiotics
inferredcites →https://doi.org/10.1111/cbdd.12517openalex-snapshot
Virulence‐targeted Antibacterials: Concept, Promise, and Susceptibility to Resistance Mechanisms
inferredcites →https://doi.org/10.1111/j.1469-0691.2006.01403.xopenalex-snapshot
Can β-lactams be re-engineered to beat MRSA?
inferredcites →https://doi.org/10.1111/j.1749-6632.2010.05828.xopenalex-snapshot
Challenges of antibacterial discovery revisited
inferredcites →https://doi.org/10.1128/aac.03774-14openalex-snapshot
Bacterial Resistance to Leucyl-tRNA Synthetase Inhibitor GSK2251052 Develops during Treatment of Complicated Urinary Tract Infections
inferredcites →https://doi.org/10.1128/aac.37.3.377openalex-snapshot
Discovery and development of new antibiotics: the problem of antibiotic resistance
inferredcites →https://doi.org/10.1128/aac.47.9.2850-2858.2003openalex-snapshot
Biological Costs and Mechanisms of Fosfomycin Resistance in Escherichia coli
inferredcites →https://doi.org/10.1128/cmr.00030-10openalex-snapshot
Challenges of Antibacterial Discovery
inferredcites →https://doi.org/10.1586/eri.11.81openalex-snapshot
Screening strategies for discovery of antibacterial natural products
inferredcites →https://doi.org/10.2174/1381612023394764openalex-snapshot
Genomics and the Prospects for the Discovery of New Targets for Antibacterial and Antifungal Agents
inferredcites →https://doi.org/10.2174/138161207782110408openalex-snapshot
The Targets of Currently Used Antibacterial Agents: Lessons for Drug Discovery
inferredcites →https://doi.org/10.2174/1568005023342227openalex-snapshot
Novel Antibacterials: A Genomics Approach to Drug Discovery
inferredcites →https://doi.org/10.2174/1568005023342597openalex-snapshot
Antibacterial Drug Discovery in the Post-Genomics Era
inferredcites →https://doi.org/10.3109/07388559209069193openalex-snapshot
The Discovery of Cell Wall Active Antibacterial Antibiotics

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.12688/openreseurope.19988.1zenodo-depositor-declared
Screening Actinomycetes extracts for antimicrobial compounds against methicillin-resistant Staphylococcus aureus and helper-compounds against aminoglycoside-resistant E. coli
inferred← citeshttps://doi.org/10.12688/openreseurope.19988.2zenodo-depositor-declared
Screening Actinomycetes extracts for antimicrobial compounds against methicillin-resistant Staphylococcus aureus and helper-compounds against aminoglycoside-resistant E. coli
inferred← citeshttps://doi.org/10.1002/adhm.202100482openalex-snapshot
Effects of Hydrophobicity on Antimicrobial Activity, Selectivity, and Functional Mechanism of Guanidinium‐Functionalized Polymers
inferred← citeshttps://doi.org/10.1002/ange.202210747openalex-snapshot
Strukturaufklärung, Totalsynthese, In‐Vivo‐Aktivität und Potentieller Biosyntheseweg des Neuen Myxobakteriellen Antibiotikums Corramycin**
inferred← citeshttps://doi.org/10.1002/ange.202414325openalex-snapshot
Innovative Wirkstoffe aus der antibakteriellen Forschung im Kampf gegen mikrobielle Resistenzen
inferred← citeshttps://doi.org/10.1002/anie.202210747openalex-snapshot
Structure Elucidation, Total Synthesis, Antibacterial In Vivo Efficacy and Biosynthesis Proposal of Myxobacterial Corramycin**
inferred← citeshttps://doi.org/10.1002/anie.202414325openalex-snapshot
Fighting Antimicrobial Resistance: Innovative Drugs in Antibacterial Research
inferred← citeshttps://doi.org/10.1002/bit.27915openalex-snapshot
Fast identification of off‐target liabilities in early antibiotic discovery with Fourier‐transform infrared spectroscopy
inferred← citeshttps://doi.org/10.1002/pro.3737openalex-snapshot
Constructing and deconstructing the bacterial cell wall
inferred← citeshttps://doi.org/10.1002/slct.202002278openalex-snapshot
Synthesis, Molecular Docking and Antimicrobial Activity of α, β‐Unsaturated Ketone Exchange Moiety for Chalcone and Pyrazoline Derivatives
inferred← citeshttps://doi.org/10.1002/slct.202202117openalex-snapshot
In Vitro Antimicrobial Screening of Benzoylthioureas: Synthesis, Antibacterial Activity toward Streptococcus agalactiae and Molecular Docking Study
inferred← citeshttps://doi.org/10.1002/slct.202503965openalex-snapshot
Design, Synthesis, Biological Evaluation, and Molecular Docking of Furopyrazines as Antibacterial Agents
inferred← citeshttps://doi.org/10.1007/7355_2016_31openalex-snapshot
Antibacterial New Target Discovery: Sentinel Examples, Strategies, and Surveying Success
inferred← citeshttps://doi.org/10.1007/7355_2017_21openalex-snapshot
Allosteric Inhibition of Bacterial Targets: An Opportunity for Discovery of Novel Antibacterial Classes
inferred← citeshttps://doi.org/10.1007/7355_2017_8openalex-snapshot
The Clinical Development of Antibacterial Drugs: A Guide for the Discovery Scientist
inferred← citeshttps://doi.org/10.1007/978-1-0716-1779-3_20openalex-snapshot
Turbidity-Based MIC Assay and Characterization of Spontaneous Drug Resistant Mutants in Mycobacterium ulcerans
inferred← citeshttps://doi.org/10.1007/978-1-0716-4848-3_1openalex-snapshot
Computer-Aided Discovery of Drugs Against Chagas Disease
inferred← citeshttps://doi.org/10.1007/978-3-319-70839-3openalex-snapshot
Antibacterials
inferred← citeshttps://doi.org/10.1007/978-981-19-1754-7_4openalex-snapshot
Antimicrobial Resistance in Ocular Bacteria
inferred← citeshttps://doi.org/10.1007/s00253-021-11102-7openalex-snapshot
Simultaneous elucidation of antibiotic mechanism of action and potency with high-throughput Fourier-transform infrared (FTIR) spectroscopy and machine learning
inferred← citeshttps://doi.org/10.1007/s11030-026-11645-9openalex-snapshot
Triazoles as enzyme inhibitors: synthetic advances, mechanism of action, molecular docking studies and structure-activity relationships
inferred← citeshttps://doi.org/10.1007/s12195-019-00572-5openalex-snapshot
Hierarchical-Clustering, Scaffold-Mining Exercises and Dynamics Simulations for Effectual Inhibitors Against Lipid-A Biosynthesis of Helicobacter pylori
inferred← citeshttps://doi.org/10.1016/b978-0-12-823974-2.00020-6openalex-snapshot
Histidinol dehydrogenase
inferred← citeshttps://doi.org/10.1016/bs.ampbs.2023.05.003openalex-snapshot
Making a chink in their armor: Current and next-generation antimicrobial strategies against the bacterial cell envelope
inferred← citeshttps://doi.org/10.1016/bs.ircmb.2023.03.009openalex-snapshot
Side effects of antibiotics and perturbations of mitochondria functions
inferred← citeshttps://doi.org/10.1016/j.bbrc.2025.152630openalex-snapshot
Boeravinone derivatives from Boerhavia diffusa potently target GMP synthase in drug-resistant Acinetobacter baumannii: An AI-guided in silico approach to combat antimicrobial resistance
inferred← citeshttps://doi.org/10.1016/j.bcp.2021.114906openalex-snapshot
Screening approaches and therapeutic targets: The two driving wheels of tuberculosis drug discovery
inferred← citeshttps://doi.org/10.1016/j.cmi.2017.06.020openalex-snapshot
Antibiotic innovation for future public health needs
inferred← citeshttps://doi.org/10.1016/j.ejmech.2023.116097openalex-snapshot
Studies of antibacterial activity (in vitro and in vivo) and mode of action for des-acyl tridecaptins (DATs)
inferred← citeshttps://doi.org/10.1016/j.jmb.2026.169892openalex-snapshot
Novel Bacterial Topoisomerase Inhibitors: A New Front in an Old War
inferred← citeshttps://doi.org/10.1016/j.micpath.2023.106108openalex-snapshot
A historical, economic, and technical-scientific approach to the current crisis in the development of antibacterial drugs: Promising role of antibacterial peptides in this scenario
inferred← citeshttps://doi.org/10.1021/acs.biochem.4c00264openalex-snapshot
Whole Cell Luminescence-Based Screen for Inhibitors of the Bacterial Sec Machinery
inferred← citeshttps://doi.org/10.1021/acs.chemrev.0c01010openalex-snapshot
β-Lactams against the Fortress of the Gram-Positive Staphylococcus aureus Bacterium
inferred← citeshttps://doi.org/10.1021/acsinfecdis.0c00724openalex-snapshot
Plasmodium Kinases as Potential Drug Targets for Malaria: Challenges and Opportunities
inferred← citeshttps://doi.org/10.1021/acsinfecdis.0c00869openalex-snapshot
Synthesis of Fusidic Acid Derivatives Yields a Potent Antibiotic with an Improved Resistance Profile
inferred← citeshttps://doi.org/10.1021/acsinfecdis.1c00171openalex-snapshot
Azaindole Based Potentiator of Antibiotics against Gram-Negative Bacteria
inferred← citeshttps://doi.org/10.1021/acsomega.4c07103openalex-snapshot
Synthesis, Hemolytic Activity, and In Silico Studies of New Bile Acid Dimers Connected with a 1,2,3-Triazole Ring
inferred← citeshttps://doi.org/10.1021/jacs.0c04427openalex-snapshot
Gram-Negative Antibiotic Active Through Inhibition of an Essential Riboswitch
inferred← citeshttps://doi.org/10.1038/s41467-025-63508-wopenalex-snapshot
The bactericidal FabI inhibitor Debio 1453 clears antibiotic-resistant Neisseria gonorrhoeae infection in vivo
inferred← citeshttps://doi.org/10.1038/s41573-020-0087-3openalex-snapshot
Improving target assessment in biomedical research: the GOT-IT recommendations
inferred← citeshttps://doi.org/10.1038/s41573-023-00791-6openalex-snapshot
Unrealized targets in the discovery of antibiotics for Gram-negative bacterial infections
inferred← citeshttps://doi.org/10.1038/s41579-019-0288-0openalex-snapshot
The global preclinical antibacterial pipeline
inferred← citeshttps://doi.org/10.1038/s41598-020-70895-1openalex-snapshot
Amygdalin based G-6-P synthase inhibitors as novel preservatives for food and pharmaceutical products
inferred← citeshttps://doi.org/10.1038/s44259-025-00115-1openalex-snapshot
Building microbial communities to improve antimicrobial strategies
inferred← citeshttps://doi.org/10.1039/d0ra05862aopenalex-snapshot
Photocatalytic and bactericidal properties and molecular docking analysis of TiO 2 nanoparticles conjugated with Zr for environmental remediation
inferred← citeshttps://doi.org/10.1080/17460441.2020.1767065openalex-snapshot
Antibacterial medicinal chemistry – what can we design for?
inferred← citeshttps://doi.org/10.1080/17568919.2026.2642582openalex-snapshot
A comprehensive review of indole hybrids as anti-bacterial and anti-fungal agents: synthetic protocols and SAR studies
inferred← citeshttps://doi.org/10.1093/jac/dkad130openalex-snapshot
The conundrum of bacteria-specific antibiotics
inferred← citeshttps://doi.org/10.1093/jac/dkz544openalex-snapshot
Antibiotics targeting bacterial ribosomal subunit biogenesis
inferred← citeshttps://doi.org/10.1101/2020.03.02.974360openalex-snapshot
Evaluating aroA gene essentiality and EPSP synthase vulnerability in Mycobacterium smegmatis under different nutritional conditions
inferred← citeshttps://doi.org/10.1111/nyas.14649openalex-snapshot
The future of antibiotics begins with discovering new combinations
inferred← citeshttps://doi.org/10.1111/nyas.15139openalex-snapshot
Weak links: Advancing target‐based drug discovery by identifying the most vulnerable targets
inferred← citeshttps://doi.org/10.1128/spectrum.00009-21openalex-snapshot
EPSP Synthase-Depleted Cells Are Aromatic Amino Acid Auxotrophs in Mycobacterium smegmatis
inferred← citeshttps://doi.org/10.1128/spectrum.02043-22openalex-snapshot
Essential Paralogous Proteins as Potential Antibiotic Multitargets in Escherichia coli
inferred← citeshttps://doi.org/10.1177/09731296241309430openalex-snapshot
Development of Chinese Medicinal Ointment with Antibacterial Properties from Tripterygium wilfordii
inferred← citeshttps://doi.org/10.1371/journal.ppat.1009384openalex-snapshot
Actives from MMV Open Access Boxes? A suggested way forward
inferred← citeshttps://doi.org/10.17863/cam.45741openalex-snapshot
The glyoxylate shunt as a target for antibacterial intervention in Pseudomonas aeruginosa
inferred← citeshttps://doi.org/10.2174/0929867330666230220140819openalex-snapshot
Chalcone Derivatives as Antibacterial Agents: An Updated Overview
inferred← citeshttps://doi.org/10.2174/2210315512666220509114733openalex-snapshot
Pharmacological Activity and Mechanism of Action of Flavonoids from Diverse Millettia Plant Organs
inferred← citeshttps://doi.org/10.24017/science.2025.2.18openalex-snapshot
Novel Fluorinated Pyrazoline Based Ethers: Synthesis, Characterization and Antimicrobial Evaluation
inferred← citeshttps://doi.org/10.31018/jans.v14i4.3693openalex-snapshot
Identification and molecular characterization of drug targets of methicillin resistant Staphylococcus aureus
inferred← citeshttps://doi.org/10.3389/fnano.2020.576342openalex-snapshot
ZnO Quantum Dots: Broad Spectrum Microbicidal Agent Against Multidrug Resistant Pathogens E. coli and C. albicans
inferred← citeshttps://doi.org/10.3390/antibiotics10020131openalex-snapshot
Staphylococcal Biofilms: Challenges and Novel Therapeutic Perspectives
inferred← citeshttps://doi.org/10.3390/antibiotics10050483openalex-snapshot
Actinomycetes: A Never-Ending Source of Bioactive Compounds—An Overview on Antibiotics Production
inferred← citeshttps://doi.org/10.3390/antibiotics10060632openalex-snapshot
In Silico Prediction and Prioritization of Novel Selective Antimicrobial Drug Targets in Escherichia coli
inferred← citeshttps://doi.org/10.3390/antibiotics11081090openalex-snapshot
In Vitro Assessment of the Combination of Antibiotics against Some Integron-Harbouring Enterobacteriaceae from Environmental Sources
inferred← citeshttps://doi.org/10.3390/antibiotics13100919openalex-snapshot
Beyond Antibiotics: What the Future Holds
inferred← citeshttps://doi.org/10.3390/biom14101225openalex-snapshot
Chloramphenicol Interferes with 50S Ribosomal Subunit Maturation via Direct and Indirect Mechanisms
inferred← citeshttps://doi.org/10.3390/books978-3-03936-659-0openalex-snapshot
Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment
inferred← citeshttps://doi.org/10.3390/ijms25020735openalex-snapshot
Fluorescent Ligand Equilibrium Displacement: A High-Throughput Method for Identification of FMN Riboswitch-Binding Small Molecules
inferred← citeshttps://doi.org/10.3390/microorganisms14081670openalex-snapshot
Design, Synthesis, and Antitubercular Activity of Thiolutin–Cycloserine Hybrids: Reducing Cytotoxicity
inferred← citeshttps://doi.org/10.3390/pathogens12030449openalex-snapshot
Antimicrobial Potential of Betulinic Acid and Investigation of the Mechanism of Action against Nuclear and Metabolic Enzymes with Molecular Modeling
inferred← citeshttps://doi.org/10.3390/pathogens9050368openalex-snapshot
Genome Subtraction and Comparison for the Identification of Novel Drug Targets against Mycobacterium avium subsp. hominissuis
inferred← citeshttps://doi.org/10.3390/pharmaceutics15020616openalex-snapshot
In Vitro Study of Biological Activity of Tanacetum vulgare Extracts
inferred← citeshttps://doi.org/10.3390/scipharm88040057openalex-snapshot
Novel Amino Acid Derivatives of Quinolines as Potential Antibacterial and Fluorophore Agents
inferred← citeshttps://doi.org/10.4062/biomolther.2023.008openalex-snapshot
Structural Insights for β-Lactam Antibiotics
inferred← citeshttps://doi.org/10.6001/biologija.v68i4.4838openalex-snapshot
Directions in the development of modern and promising antimicrobial agents
inferred← citeshttps://doi.org/10.70675/431a4791z1d6cz4edfzb31azd846ac39cb40openalex-snapshot
Regulated activity of a bacterial transenvelope machinery : the LPS Transport System
inferred← citeshttps://doi.org/10.70675/500c7118z10f4z4d35zb23dz5a4d0cbc4e59openalex-snapshot
Synthetic biology and open science : the next frontier of antibiotic discovery and antimicrobial resistance research
inferred← citeshttps://doi.org/10.7554/elife.98266.1openalex-snapshot
Dimer-monomer transition defines a novel hyper-thermostable peptidoglycan hydrolase mined from bacterial proteome
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.